Atlas FDA

AAV5 DetectCDx®

FDA premarket approval P190033/S001 · decided 2024-10-04

Approval details

PMA number
P190033
Supplement
S001
Supplement type
30-Day Notice
Supplement reason
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Trade name
AAV5 DetectCDx®
Generic name
Assays to detect pre-existing antibodies to adeno-associated virus (AAV) viral vectors
Applicant
ARUP Laboratories
Date received
2024-09-05
Decision date
2024-10-04
Days to decision
29 days
Decision code
OK30
Product code
QWQ
Advisory committee
Hematology
Expedited review
No
Location
Salt Lake City, UT
Statement
To change the scale of size exclusion chromatography, and accept SULFO-TAG AAV5 Capsid below previously-defined method acceptance criteria.

Class III intelligence, same tools

PMAs share the API, exports and alerts with 510(k) data - watch an applicant and hear about every approval.